CTEV Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

Total Revenue: $244.7 million, up 5.8% year-over-year.
Adjusted EBITDA: $146.9 million, up 3.4% year-over-year, with a margin of 60%.
Unlevered Free Cash Flow: $36.8 million, up 181% year-over-year.
Annual Contract Value (ACV) Bookings: $44.1 million in Q1, contributing to a target of $80 million to $100 million for the year, representing a 20% to 50% increase over last year.
Cash Flow Usage: $92.5 million, attributed to increased working capital and a fully annualized cash interest payment schedule.

2. Strategic Updates and Business Highlights

Market Position: Claritev emphasizes its competitive advantages in client relationships, data ecosystem, and AI application, which are critical for driving growth.
New Contracts: Secured a partnership with GDIT for the World Trade Center Health Program and signed a top 5 health system, enhancing its presence in the public sector and provider verticals.
AI Integration: Significant improvements in operational efficiency through AI, doubling coding capacity without increasing headcount and automating invoice processing.
Diversification Strategy: Continued focus on expanding into new markets, including TPA (Third Party Administrator) and public sector, with a notable increase in pipeline growth (70% year-over-year).

3. Forward Guidance and Outlook

Revenue Guidance: Raised the bottom end of the revenue guidance to $985 million to $1 billion for the year.
Adjusted EBITDA Guidance: Maintained at $605 million to $615 million, with margins of 61% to 62%.
Future Growth: Anticipated growth rates of 3% to 5% in the second half of the year as new ACV ramps up.

4. Bad News, Challenges, or Points of Concern

Cash Flow Dynamics: Q1 is typically a cash consumption quarter, and the normalization of cash interest payments has impacted cash flow.
Volume Declines: Noted a decline in PSAV claims volume, although this was offset by favorable trends in rate mix.
Market Pressures: Competitive pressures in the Medicare Advantage space may lead to increased demand for payment integrity solutions, indicating a need for heightened operational efficiency among payers.

5. Notable Q&A Insights

Margin Dynamics: Management indicated that investments made in Q4 2025 may have temporarily burdened margins, but expect stable or slightly improving margins in the second half of 2026 as ACV converts to revenue.
Utilization Environment: There has been a slight decline in volumes, particularly in outpatient settings, but higher acuity claims are driving savings and revenue.
Service Bookings Mix: Approximately 20% of Q1 bookings came from provider and public sector markets, with expected margins on these services to be about half of the core business.
Medicare Advantage Impact: Limited immediate impact from regulatory changes on claims volume, but potential long-term opportunities as payers seek efficiency.

This summary encapsulates the key takeaways from Claritev's Q1 2026 earnings call, highlighting the company's financial performance, strategic initiatives, and outlook while addressing challenges and insights from the Q&A session.

CTEV — Claritev Corporation